版本:
中国

BRIEF-Dimension Therapeutics announces orphan drug designation of DTX401

Oct 4 Dimension Therapeutics Inc

* Dimension Therapeutics announces orphan drug designation of DTX401 for the treatment of glycogen storage disease type IA (GSDIA) Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐